Stabilized pharmaceutical composition
AssigneeTakeda Chemical Industries, Ltd.
InventorsTadashi Makino, Tetsuro Tabata, Shin-Ichiro Hirai
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Chemical Industries, Ltd.
InventorsTadashi Makino, Tetsuro Tabata, Shin-Ichiro Hirai
Estimating the term…
The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula 1 wherein R1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy, carboalkoxyalkyl, carbamoyl, carbamoylalkyl, hydroxy, alkoxy, hydroxyalkyl, trifluoromethyl, acyl, carbamoyloxy, nitro, acyloxy, aryl, aryloxy, alkylthio or alkylsulfinyl, R2 is hydrogen, alkyl, acyl, carboalkoxy, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, alkylcarbonyl-methyl, alkoxycarbonylmethyl or alkylsulfonyl, R3 and R5 are the same or different and each is hydrogen, alkyl, alkoxy or alkoxyalkoxy, R4 is hydrogen, alkyl, alkoxy which may optionally be fluorinated, or alkoxyalkoxy, and m is an integer of 0 through 4, and a basic inorganic salt stabilizing agent, is physically stable. Magnesium and calcium basic inorganic salt stabilizing agents are particularly useful.
A method of stabilizing an enteric coated anti-ulcer composition, which comprises:
Dependencies are inferred from the claim text.